Trial
NCT01153919
Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Southern California
Collaborators
—
Condition
Hepatitis C Infection
Intervention
romiplostim
Why stopped
Approval of several new agents for the treatment of HCV infection would mitigate the future need for interferon HCV treatment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-11